Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Illumina, Inc. is a global leader in genetic and genomic analysis, providing sequencing and array-based solutions for research, clinical, and applied markets. Its products include instruments, consumables, and analysis tools used in genomics research, diagnostics, and personalized medicine. Serving research institutions, healthcare providers, and biotech companies, Illumina's core value lies in advancing genetic understanding and enabling precision health through innovative, high-throughput sequencing technologies.
This description was generated via AI from an annual report. Updated about 1 year ago.